$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How much does cimepilimab cost? Are the prices different for different strengths and dosages?
2026-02-01 22:25:32
Check Details
What is the latest market price of daprestat in 2025? Has there been an increase or change?
2026-02-01 22:25:32
Check Details
How effective is zotuximab as a new drug for the treatment of gastric cancer? What are its clinical efficacy and application prospects?
2026-02-01 22:25:32
Check Details
What diseases does durvalumab (durvalumab) mainly treat? How effective is it in treating tumors?
2026-02-01 22:25:32
Check Details
What generic versions of Atropine Sulfate Eye Drops 0.01% are available on the market? Do these generic drugs work the same as the genuine products?
2026-02-01 22:25:32
Check Details
How should I take Avonib? Is it more appropriate to take it before or after meals?
2026-02-01 22:25:32
Check Details
What are the side effects of mitotane? What adverse reactions may occur with long-term use?
2026-02-01 22:25:32
Check Details
What are the generic versions of Pemetinib? Are the Indian version, Laos version and other versions reliable in their efficacy?
2026-02-01 22:25:32
Check Details
What is the maximum duration of taking erdafitinib? Are there any risks in taking it overtime?
2026-02-01 22:25:32
Check Details
Guidelines for use of margetuximab: key information and precautions
2026-02-01 22:25:32
Check Details
What important information is included in the package insert for Dacomitinib? What are the key things to pay attention to when using it?
2026-02-01 22:25:32
Check Details
Which generation of targeted drug is brigatinib? What are its unique advantages compared with other targeted drugs?
2026-02-01 22:25:32
Check Details
1
2
...
1382
1383
1384
1385
1386
1387
1388
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Revumenib: Key Considerations Before and During Treatment
3
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
4
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
5
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
6
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
7
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
8
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
9
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
10
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
11
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
12
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure